Completed
A Trial Investigating the Pharmacodynamic Properties of NN1218 in Subjects With Type 1 Diabetes
NCT01618188
- Conditions
- Autoimmune Diseases, Diabetes, Diabetes Mellitus, +6 more
- Locations
-
- Novo Nordisk Investigational Site Neuss, Germany